Stay updated on Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Recruitment status on the study page now shows 'No longer looking for participants,' indicating enrollment is complete. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label, with the revision tag updated to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T15:37:53.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates the page's revision was updated to a newer version.
    Difference
    0.0%
    Check dated 2026-06-05T11:15:46.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.5.3 to v3.5.4, indicating a minor update to the study details page metadata. This reflects an internal revision rather than changes to the study data or content.
    Difference
    0.0%
    Check dated 2026-05-15T05:34:05.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Updates the Chile location listing to use shorter region labels (e.g., Araucania and Valparaiso) alongside the corresponding city/state entries, and updates the displayed site revision version.
    Difference
    0.4%
    Check dated 2026-04-24T05:44:21.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:17:38.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Added Padova, Italy, 35128 as a study location and removed Padua, Italy, 35128.
    Difference
    0.0%
    Check dated 2026-04-09T20:34:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Lenvatinib in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Lenvatinib in Melanoma Clinical Trial page.